ArticleNeurology and therapy2025

Selective S1P Receptor Modulation in Multiple Sclerosis Alters CXCL13:CXCR5-Associated Immune Activities Without Impacting Anti-SARS-CoV-2 Immunity.

Andrea Harrer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.